CareDx, Inc (NASDAQ:CDNA) Q4 2023 Earnings Call Transcript
CareDx, Inc beats earnings expectations. Reported EPS is $-0.17, expectations were $-0.24.
Stay updated with breaking news from Testing Services. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CareDx, Inc beats earnings expectations. Reported EPS is $-0.17, expectations were $-0.24.
CareDx, Inc (NASDAQ:CDNA) Q4 2023 Earnings Call Transcript February 28, 2024 CareDx, Inc beats earnings expectations. Reported EPS is $-0.17, expectations were $-0.24. CDNA isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings, and welcome to CareDx, Inc. Fourth Quarter […]
Full Year Revenue Exceeds Guidance; Patent Litigation Impacts Net Loss
Stock analysts at StockNews.com began coverage on shares of Applied DNA Sciences (NASDAQ:APDN – Get Free Report) in a research report issued to clients and investors on Sunday. The firm set a “hold” rating on the technology company’s stock. Separately, HC Wainwright lowered their price target on shares of Applied DNA Sciences from $2.00 to […]
Company Raises 2024 Revenue Guidance and Delivers Positive Adjusted EPS in Q4